Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Complimentary download
Iden Biotechnology, a specialist in crop improvement and agrobiological products, completes €4M capital increase with CRB Inverbío and Sodena
Recommend Report
Need some help to find your information ?
E-mail:
econtact@cnchemicals.com
Tel: +86-20-37616606
Search Report
Agriculture
Biotechnology
Chemicals
Economics and investment and financial
Energy and utilities
Food and Feed
Food and Feed (Ingredients)
Minerals/resources/mining
Pharmaceuticals and healthcare
Printing & packaging
More Reports >>
Recommend Newsletter
Related market data
Related product
Related research
Iden Biotechnology, a specialist in crop improvement and agrobiological products, completes €4M capital increase with CRB Inverbío and Sodena
Keyword:
Publish time:
5
th
March, 2015
Source:
Spain
Information collection and data processing: CCM For more information, please
contact us
Iden Biotechnology, a specialist in crop improvement and agrobiological products, completes €4M capital increase with CRB Inverbío and SodenaIden Biotechnology, a specialist in crop improvement and agrobiological products, completes €4M capital increase with CRB Inverbío and Sodena" title="Share this link on Facebook">SpainFebruary 26, 2015CRB Inverbío has led a €3 million investment in Iden Biotechnology through its CRB Bio II FCR fund, along with the public company SODENA that contributes with an additional €1 million. The total round, which amounts to €4 million euro, will allow the company to extend its R&D facilities and staff in Navarra, and to strengthen its R&D development programs for crop improvement and agrobiological product.CRB Bio II fund becomes the main shareholder in the company and together with the funding team, INFARCO (Cinfa’s parent company), the Spanish National Research council (CSIC) and SODENA, creates a stable shareholding base for IDEN.Iden was founded in 2005 by members of the research group of Carbohydrate Metabolism of the Agrobiotechnology Institute of Navarra (IdaB), a joint center between the Public University of Navarra (UPNA), the CSIC, and the Government of Navarra. Iden focuses on two main areas: i) the identification and development of vegetal genes with agronomic value for the improvement of crop yield and quality, and, ii) the development of biological compounds that, , provide higher yield and resistance and whenapplied to the
crops
, thus reducing the use of
agrochemical
products.The Company has been very active internationally and has reached several licensing and codevelopment agreements of its technology with companies in USA, South America and India, among others. It is also working alongside prospective investors to strengthen the capital structure and accelerate the execution of the Company’s business plan.Nora Alonso, founder and Managing Director of the company, stressed that “the incorporation of two investors with the experience and capacity of CRB Inverbío and Sodena, grants the company the financial resources and management capacities for the execution of an ambitious plan for the next three years”.Angel Santos, partner of CRB Inverbío and new Chairman of the Board ensures that “this round reinforces our commitment with Iden and its sound portfolio and outstanding leadership potential in a sector that has great value creation opportunities and that is already attracting high interest from financial and industrial investors, worldwide.More news from: Iden Biotechnology S.L.Website: http://www.cnchemicals.com/: March 5, 2015The news item on this page is copyright by the organization where it originatedFair use notice
Index Type:(required)
-- Please select --
Message:(required)
Name:(required)
Email:(required)
Tel:
Message:(required)
Name:(required)
Email:(required)
Tel: